Alternatives to VISEN Pharmaceuticals

VISEN Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies for inflammatory and fibrotic diseases. Here are the 60 closest alternatives, compared on pricing, features and what real users say.

VISEN Pharmaceuticals profile More Biotech alternatives

The 20 closest Biotech companies to VISEN Pharmaceuticals

Adaptive Biotechnologies
Not rated
Leveraging the adaptive immune system to diagnose and treat disease.
Visit site
BeiGene
Not rated
A global oncology company developing and commercializing innovative cancer treatments.
Visit site
Synthace
Not rated
Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.
Visit site
Lexeo Therapeutics
Not rated
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
Visit site
Caris Life Sciences
Not rated
Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
Visit site
Cue Biopharma
Not rated
Developing engineered biologics to harness the immune system for disease treatment.
Visit site
Guardant Health
Not rated
Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
Visit site
Harmony Biosciences Holdings
Not rated
Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.
Visit site
Amicus Therapeutics
Not rated
Biotechnology company focused on developing treatments for rare metabolic diseases.
Visit site
Sylentis
Not rated
Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.
Visit site
Cellcolabs
Not rated
AI-powered platform for personalized cell therapy development and manufacturing.
Visit site
Regenxbio
Not rated
Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.
Visit site
Tenaya Therapeutics
Not rated
Biotechnology company developing gene therapies and regenerative medicine for heart disease.
Visit site
Alector
Not rated
Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
Visit site
BioLife Solutions
Not rated
Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.
Visit site
Tharimmune
Not rated
Biotechnology company developing novel immunotherapies for cancer.
Visit site
Avidity Biosciences
Not rated
Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
Visit site
Syantra
Not rated
A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.
Visit site
Rezolute
Not rated
Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.
Visit site
Bluebird Bio
Not rated
Gene therapy company developing transformative treatments for severe genetic diseases.
Visit site

Company	Rating	Visit
Adaptive BiotechnologiesLeveraging the adaptive immune system to diagnose and treat disease.	Not rated	Visit site
BeiGeneA global oncology company developing and commercializing innovative cancer treatments.	Not rated	Visit site
SynthaceSynthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.	Not rated	Visit site
Lexeo TherapeuticsClinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.	Not rated	Visit site
Caris Life SciencesCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.	Not rated	Visit site
Cue BiopharmaDeveloping engineered biologics to harness the immune system for disease treatment.	Not rated	Visit site
Guardant HealthGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.	Not rated	Visit site
Harmony Biosciences HoldingsBiopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.	Not rated	Visit site
Amicus TherapeuticsBiotechnology company focused on developing treatments for rare metabolic diseases.	Not rated	Visit site
SylentisOphthalmic pharmaceutical company developing novel treatments for ocular diseases.	Not rated	Visit site
CellcolabsAI-powered platform for personalized cell therapy development and manufacturing.	Not rated	Visit site
RegenxbioClinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.	Not rated	Visit site
Tenaya TherapeuticsBiotechnology company developing gene therapies and regenerative medicine for heart disease.	Not rated	Visit site
AlectorBiotechnology company developing immuno-neurology therapies for neurodegenerative diseases.	Not rated	Visit site
BioLife SolutionsDevelops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.	Not rated	Visit site
TharimmuneBiotechnology company developing novel immunotherapies for cancer.	Not rated	Visit site
Avidity BiosciencesClinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.	Not rated	Visit site
SyantraA precision biotechnology company developing a blood-based platform for early cancer detection and treatment.	Not rated	Visit site
RezoluteBiopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.	Not rated	Visit site
Bluebird BioGene therapy company developing transformative treatments for severe genetic diseases.	Not rated	Visit site

Showing the next 20 closest matches. See the rest on the VISEN Pharmaceuticals profile.

Sponsored rows are paid and labelled. Advertise on this page